Philips to distribute 4DMedical’s cutting-edge lung health technology across U.S.

In a monumental move set to shake up the U.S. healthcare industry, 4DMedical has just announced a comprehensive distribution agreement with global healthcare giant Philips. The partnership will see Philips becoming the exclusive distributor of 4DMedical’s cutting-edge lung imaging products to U.S. government agencies, including the Department of Veterans Affairs (VA) and the Department of Defense (DoD). This five-year agreement will also allow Philips to sell the technology to other U.S. commercial customers on a non-exclusive basis.

The potential impact of this deal on the U.S. healthcare market is enormous. Leveraging Philips’ well-established relationships, particularly within the VA and DoD, 4DMedical is poised to make a substantial mark on the healthcare industry. These institutions have been at the forefront of addressing respiratory issues among veterans, who suffer from chronic lung diseases at rates three times higher than the general population. The signing of this agreement signals a powerful shift towards enhancing lung health and expanding respiratory care for millions across the country.

4DMedical, renowned for its breakthrough in respiratory imaging technology, had been working in collaboration with Philips since early 2024. Both companies have been developing innovative lung screening solutions, particularly focusing on toxic exposure in military settings and deployment-related respiratory diseases. The timing couldn’t be better, as the PACT Act, a $280 billion commitment to veteran healthcare, promises to bring renewed attention to lung health, providing a unique market opportunity for the two firms.

This partnership also brings promising financial growth for both companies. Philips will earn a margin of up to 35% on the sales of 4DMedical’s suite of products, including the revolutionary XV Lung Ventilation Analysis Software (XV LVAS) and CT Lung Ventilation Analysis Software (CT LVAS). Reimbursement codes for these lung scans have already been secured, offering an enticing financial pathway for healthcare providers, with payments as high as $650 per scan. This comes as a significant incentive for hospitals and clinics across the U.S. to adopt these non-invasive, life-saving technologies.

An Expert’s View on the Agreement

Healthcare experts are hailing this agreement as a game-changer. Industry analysts believe that the U.S. lung health market, particularly within the VA and DoD, has been in dire need of scalable, innovative solutions. The involvement of Philips, a company with over four decades of experience in providing imaging solutions, is expected to fast-track the widespread adoption of 4DMedical’s technologies. One industry expert noted that Philips’ deep-rooted presence in U.S. government healthcare, with over 50% of VA clinics already using their imaging solutions, places them in a perfect position to drive the market for respiratory care.

The veteran population has been grappling with a surge in respiratory diseases, and this partnership comes as a beacon of hope for millions. With Philips’ proven track record and 4DMedical’s advanced technology, the future of lung health in the U.S. looks promising. The agreement marks the beginning of a new era in respiratory healthcare, where early diagnosis and targeted treatment of lung diseases like COPD, asthma, and interstitial lung disease could become the norm.

This historic partnership is more than just a business deal; it is a bold step toward reshaping lung health care in the United States.